Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INZY | NBP | ALXO | ||
| Company | Inozyme Pharma Inc | Novabridge Biosciences ADR | Alx Oncology Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.00 | 2.27 | 1.9300 | ||
| High | 4.00 | 2.40 | 2.0450 | ||
| Low | 3.99 | 2.23 | 1.9300 | ||
| Latest | 4.00 | 2.37 | 2.0100 | ||
| Change | +0.01 | +0.13 | +0.1000 | ||
| % Change | +0.25% | +5.80% | +5.24% | ||
| Volume | 1,459,400 | 740,202 | 188,358 | ||
| 20-Day Average Volume | 1,079,340 | 984,638 | 659,565 | ||
| Previous Close | 3.99 | 2.24 | 1.9100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.99 | 2.87 | 2.0955 | ||
| 20-Day Raw Stochastic | 100.00% | 16.19% | 38.86% | ||
| 20-Day Relative Strength | 81.11 | 35.76 | 49.21 | ||
| Weighted Alpha | -60.68 | +4.25 | +94.49 | ||
| Today's Opinion | 88% Buy | 100% Sell | 64% Buy | ||
| Previous Opinion | 80% Buy | 88% Sell | 64% Buy | ||
| Last Month's Opinion | 40% Buy | 56% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.25% since 06/23/25 | -5.36% since 03/24/26 | -0.98% since 03/24/26 | ||
| Low | 3.99 on 06/30/25 | 2.10 on 03/30/26 | 1.8050 on 03/30/26 | ||
| High | 4.00 on 06/30/25 | 2.77 on 03/25/26 | 2.2000 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +0.76% since 05/30/25 | -27.29% since 02/27/26 | -4.27% since 02/27/26 | ||
| Low | 3.96 on 06/02/25 | 2.10 on 03/30/26 | 1.8050 on 03/30/26 | ||
| High | 4.00 on 06/30/25 | 3.86 on 03/05/26 | 2.3583 on 03/06/26 | ||
| 3-Month | |||||
| %Chg | +334.69% since 03/28/25 | -45.05% since 12/26/25 | +51.88% since 12/26/25 | ||
| Low | 0.72 on 04/07/25 | 2.10 on 03/30/26 | 1.0700 on 01/06/26 | ||
| High | 4.00 on 06/30/25 | 5.19 on 01/06/26 | 2.6600 on 02/19/26 | ||
| 6-Month | |||||
| %Chg | +41.84% since 12/30/24 | -31.47% since 09/26/25 | +8.02% since 09/26/25 | ||
| Low | 0.72 on 04/07/25 | 2.10 on 03/30/26 | 1.0500 on 11/07/25 | ||
| High | 4.00 on 06/30/25 | 6.79 on 10/16/25 | 2.6600 on 02/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 258,248 | 258,252 | 251,371 | ||
| Shares Outstanding, K | 64,562 | 115,291 | 131,608 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -102,020,000 | -22,230,000 | -101,700,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -28,040,000 | -5,500,000 | -22,850,000 | ||
| 60-Month Beta | 2.27 | 1.60 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 05/14/25 | -0.07 on 08/20/25 | -0.42 on 02/27/26 | ||
| Latest Earnings Date | 08/05/25 | 04/02/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||